IBDEI1CA ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22767,1,3,0)
 ;;=3^Cirrhosis of Liver,Unspec
 ;;^UTILITY(U,$J,358.3,22767,1,4,0)
 ;;=4^K74.60
 ;;^UTILITY(U,$J,358.3,22767,2)
 ;;=^5008822
 ;;^UTILITY(U,$J,358.3,22768,0)
 ;;=K76.0^^87^984^12
 ;;^UTILITY(U,$J,358.3,22768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22768,1,3,0)
 ;;=3^Fatty Liver NEC
 ;;^UTILITY(U,$J,358.3,22768,1,4,0)
 ;;=4^K76.0
 ;;^UTILITY(U,$J,358.3,22768,2)
 ;;=^5008831
 ;;^UTILITY(U,$J,358.3,22769,0)
 ;;=K76.89^^87^984^18
 ;;^UTILITY(U,$J,358.3,22769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22769,1,3,0)
 ;;=3^Liver Disease NEC
 ;;^UTILITY(U,$J,358.3,22769,1,4,0)
 ;;=4^K76.89
 ;;^UTILITY(U,$J,358.3,22769,2)
 ;;=^5008835
 ;;^UTILITY(U,$J,358.3,22770,0)
 ;;=K71.6^^87^984^32
 ;;^UTILITY(U,$J,358.3,22770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22770,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,22770,1,4,0)
 ;;=4^K71.6
 ;;^UTILITY(U,$J,358.3,22770,2)
 ;;=^5008801
 ;;^UTILITY(U,$J,358.3,22771,0)
 ;;=K75.9^^87^984^17
 ;;^UTILITY(U,$J,358.3,22771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22771,1,3,0)
 ;;=3^Inflammatory Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,22771,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,22771,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,22772,0)
 ;;=K71.0^^87^984^24
 ;;^UTILITY(U,$J,358.3,22772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22772,1,3,0)
 ;;=3^Toxic Liver Disease w/ Cholestasis
 ;;^UTILITY(U,$J,358.3,22772,1,4,0)
 ;;=4^K71.0
 ;;^UTILITY(U,$J,358.3,22772,2)
 ;;=^5008793
 ;;^UTILITY(U,$J,358.3,22773,0)
 ;;=K71.10^^87^984^30
 ;;^UTILITY(U,$J,358.3,22773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22773,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
 ;;^UTILITY(U,$J,358.3,22773,1,4,0)
 ;;=4^K71.10
 ;;^UTILITY(U,$J,358.3,22773,2)
 ;;=^5008794
 ;;^UTILITY(U,$J,358.3,22774,0)
 ;;=K71.11^^87^984^31
 ;;^UTILITY(U,$J,358.3,22774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22774,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
 ;;^UTILITY(U,$J,358.3,22774,1,4,0)
 ;;=4^K71.11
 ;;^UTILITY(U,$J,358.3,22774,2)
 ;;=^5008795
 ;;^UTILITY(U,$J,358.3,22775,0)
 ;;=K71.2^^87^984^23
 ;;^UTILITY(U,$J,358.3,22775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22775,1,3,0)
 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
 ;;^UTILITY(U,$J,358.3,22775,1,4,0)
 ;;=4^K71.2
 ;;^UTILITY(U,$J,358.3,22775,2)
 ;;=^5008796
 ;;^UTILITY(U,$J,358.3,22776,0)
 ;;=K71.3^^87^984^28
 ;;^UTILITY(U,$J,358.3,22776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22776,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
 ;;^UTILITY(U,$J,358.3,22776,1,4,0)
 ;;=4^K71.3
 ;;^UTILITY(U,$J,358.3,22776,2)
 ;;=^5008797
 ;;^UTILITY(U,$J,358.3,22777,0)
 ;;=K71.4^^87^984^27
 ;;^UTILITY(U,$J,358.3,22777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22777,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
 ;;^UTILITY(U,$J,358.3,22777,1,4,0)
 ;;=4^K71.4
 ;;^UTILITY(U,$J,358.3,22777,2)
 ;;=^5008798
 ;;^UTILITY(U,$J,358.3,22778,0)
 ;;=K75.81^^87^984^19
 ;;^UTILITY(U,$J,358.3,22778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22778,1,3,0)
 ;;=3^Nonalcoholic Steatohepatitis (NASH)
 ;;^UTILITY(U,$J,358.3,22778,1,4,0)
 ;;=4^K75.81
 ;;^UTILITY(U,$J,358.3,22778,2)
 ;;=^5008828
 ;;^UTILITY(U,$J,358.3,22779,0)
 ;;=K75.89^^87^984^16
 ;;^UTILITY(U,$J,358.3,22779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22779,1,3,0)
 ;;=3^Inflammatory Liver Disease,Oth Spec
 ;;^UTILITY(U,$J,358.3,22779,1,4,0)
 ;;=4^K75.89
 ;;^UTILITY(U,$J,358.3,22779,2)
 ;;=^5008829
 ;;^UTILITY(U,$J,358.3,22780,0)
 ;;=K76.4^^87^984^21
